Ayurvedic treatment for Benign Prostatic Hyperplasia with Mustadi Gana Kwatha and Swadamstradi Taila

A Phytochemical In Silico and Clinical Study of Mustadi Gana Kwatha and Swadamstradi Taila in the management of Benign Prostatic Hyperplasia - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070823

Enrollment

Registered

2024-07-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: diagnosed cases of BPH, without acute retention of urine all grades of BPH without acute retention of urine

Exclusion criteria

Exclusion criteria: Patients with bladder neck stenosis acute urinary retention known case of systemic diseases like TB Hepatitis B HIV Hepatitis C Cardiac diseases uncontrolled DM urethral stricture Neurogenic bladder ARF and CRF veneral diseases

Design outcomes

Primary

Measure	Time frame
Disease specific subjective parameters based on IPSS score objective parameters like weight of prostate and PVRU by USG whole abdomen with prostate and PVRU Timepoint: Basti will be administered for a period of 15 days followed by follow up every 4 weeks for a period of 12 weeks	—

Secondary

Measure	Time frame
Relief in signs and symptoms of BPHTimepoint: for a period of 3months	—

Countries

India

Contacts

Public ContactDr Sunil Kumar Mishra

Banaras Hindu University

drarunbhu@gmail.com9161499774

Outcome results